Screening for colorectal cancer in Tianhe, Guangzhou: results of combining fecal immunochemical tests and risk factors for selecting patients requiring colonoscopy

Abstract

ObjectiveTo explore the performance of a protocol combining fecal immunochemical test (FIT) and a high-risk factor questionnaire (HRFQ) for selecting patients requiring colonoscopy as part of a population-based colorectal cancer (CRC) screening program in China.MethodsFrom 2015 to 2016, we conducted a CRC screening program for all residents aged 45 years or older in Tianhe District, Guangzhou City, China. Participants underwent an FIT and received an HRFQ as part of primary screening. Those with positive FIT and/or HRFQ results were considered to be at high risk and were recommended to undergo colonoscopy.ResultsA total of 10 074 subjects were recruited and enrolled in the screening program. In the enrolled population, 17.5% had positive FIT results and 19.4% had positive HRFQ results. Of those recommended to undergo diagnostic colonoscopy, 773 did so. The screening method’s overall positive predictive value (PPV) was 4.9% for non-adenomatous polyps, 11.4% for low-risk adenomas (LRAs), 15.9% for high-risk adenomas (HRAs) and 1.6% for CRC. The PPVs of positive FIT results for non-adenomatous polyps, LRAs, HRAs and CRC were 5.2%, 15.9%, 22.5% and 2.5%, respectively. The PPVs of positive HRFQ results for non-adenomatous polyps, LRA, HRA and CRC were 4.1%, 10.2%, 14.3% and 1.4%, respectively. The PPVs associated with combined positive FIT and HRFQ results for non-adenomatous polyps, LRAs, HRAs and CRC were 4.5%, 16.4%, 23.7% and 2.8%, respectively.ConclusionOur results suggest that this two-step CRC screening strategy, involving a combination of FIT and HRFQ followed by colonoscopy, is useful to identify early-stage CRC. The high detection rates and PPVs for CRC and adenomas encourage this strategy’s use in ongoing screening programs.

Clinicopathological and Prognostic Characteristics of RAD51 in Colorectal Cancer

“…Genetic changes in CRC have been broadly continued. Although many authors have studied the epidemiology of CRC for a long time [3][4][5][6], little is known about the latest tendencies of the demographic features and genetic alterations of CRC.…”

Improved diagnostic value by combining plasma PON1 level with tumor biomarkers in Colorectal Cancer patients

“…The first step in screening is to identify the patient's level of risk for CRC, while the second step is to take a diagnostic screening for high-risk patients. Fecal occult blood test and high-risk questionnaire of medical history are used as screening methods at present, however their sensitivity and specificity are low 5 , 6 . Colonoscopy remains the golden standard to diagnose CRC whose advantage is accurate and accessible to biopsy for pathological examination.…”

Demographic trends and KRAS/BRAFV600E mutations in colorectal cancer patients of South China: A single‐site report

“…CRC has become the fifth most common cancer and the fifth leading cause of cancer death . In Guangzhou, a more developed coast area in South China, CRC incidence has reached 34/100,000, according to the data from Guangzhou Center for Disease Control and Prevention . Although various researchers have studied the epidemiology of CRC over the past decades, little is known about the latest tendencies of demographic features and genetic alterations of CRC in China.…”